<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38800803</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.</ArticleTitle><Pagination><StartPage>102638</StartPage><MedlinePgn>102638</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102638</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102638</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID is the patient-coined term for the persistent symptoms of COVID-19 illness for weeks, months or years following the acute infection. There is a large burden of long COVID globally from self-reported data, but the epidemiology, causes and treatments remain poorly understood. Primary care is used to help identify and treat patients with long COVID and therefore Electronic Health Records (EHRs) of past COVID-19 patients could be used to help fill these knowledge gaps. We aimed to describe the incidence and differences in demographic and clinical characteristics in recorded long COVID in primary care records in England.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">With the approval of NHS England we used routine clinical data from over 19 million adults in England linked to SARS-COV-2 test result, hospitalisation and vaccination data to describe trends in the recording of 16 clinical codes related to long COVID between November 2020 and January 2023. Using OpenSAFELY, we calculated rates per 100,000 person-years and plotted how these changed over time. We compared crude and adjusted (for age, sex, 9 NHS regions of England, and the dominant variant circulating) rates of recorded long COVID in patient records between different key demographic and vaccination characteristics using negative binomial models.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">We identified a total of 55,465 people recorded to have long COVID over the study period, which included 20,025 diagnoses codes and 35,440 codes for further assessment. The incidence of new long COVID records increased steadily over 2021, and declined over 2022. The overall rate per 100,000 person-years was 177.5 cases in women (95% CI: 175.5-179) and 100.5 in men (99.5-102). The majority of those with a long COVID record did not have a recorded positive SARS-COV-2 test 12 or more weeks before the long COVID record.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">In this descriptive study, EHR recorded long COVID was very low between 2020 and 2023, and incident records of long COVID declined over 2022. Using EHR diagnostic or referral codes unfortunately has major limitations in identifying and ascertaining true cases and timing of long COVID.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This research was supported by the National Institute for Health and Care Research (NIHR) (OpenPROMPT: COV-LT2-0073).</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Alasdair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler-Cole</LastName><ForeName>Ben Fc</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tazare</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jit</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Liang-Yu</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlile</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacon</LastName><ForeName>Sebastian Cj</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillingham</LastName><ForeName>Iain</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennison</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Patient and Public Involvement Steering Committee, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costello</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yinghui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre for Mathematical Sciences, School of Engineering, Computing and Mathematics, University of Plymouth, Plymouth, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulme</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrkar</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacKenna</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OpenSAFELY Collaborative</CollectiveName></Author><Author ValidYN="Y"><LastName>Herrett</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggo</LastName><ForeName>Rosalind M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Descriptive cohort</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare the following: LAT reports grants from MRC, Wellcome, NIHR in the past 3 years. MJ reports funding from BMGF, Gavi, RCUK, BMGF, WHO, Gavi, Wellcome Trust, European Commission, InnoHK, TFGH, CDC to their institution over the past 3 years. AB has received consultancy fees within the past 3 years from AstraZeneca, Takeda, Daiichi-Sankyo, Eisai, Roche, Novartis, Idorsia &amp; Rythmn. CB &amp; JP are employees of TPP (Leeds) Ltd who provide SystmOne and process data for OpenSafely under the instruction of NHS England. REC holds personal shares in AstraZeneca unrelated to this work. BG has received research funding from the Bennett Foundation, the Laura and John Arnold Foundation, the NHS National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, NHS England, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, the World Health Organisation, UKRI MRC, Asthma UK, the British Lung Foundation, and the Longitudinal Health and Wellbeing strand of the National Core Studies programme; he has previously been a Non-Executive Director at NHS Digital; he also receives personal income from speaking and writing for lay audiences on the misuse of science. AM has represented the RCGP in the health informatics group and the Profession Advisory Group that advises on access to GP Data for Pandemic Planning and Research (GDPPR); the latter was a paid role. AM is a former employee and interim Chief Medical Officer of NHS Digital. AM has consulted for health care vendors, the last time in 2022; the companies consulted in the last 3 years have no relationship to OpenSAFELY. BMK is also employed by NHS England working on medicines policy and clinical lead for primary care medicines data. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Amelia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehrkar</LastName><ForeName>Amir</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaffer</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butler-Cole</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacKenna</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morton</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walters</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stables</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andrews</LastName><ForeName>Colm</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hickman</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curtis</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drysdale</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillingham</LastName><ForeName>Iain</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massey</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nab</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hopcroft</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bridges</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wiedemann</LastName><ForeName>Milan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeVito</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macdonald</LastName><ForeName>Orla</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Inglesby</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croker</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Robin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higgins</LastName><ForeName>Rose</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacon</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davy</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maude</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Dwyer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Speed</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hulme</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hart</LastName><ForeName>Liam</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stokes</LastName><ForeName>Pete</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhaskaran</LastName><ForeName>Krishnan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costello</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cowling</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eggo</LastName><ForeName>Rosalind</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>Harriet</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grieve</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grint</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrett</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langan</LastName><ForeName>Sinead</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahalingasivam</LastName><ForeName>Viyaasan</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mansfield</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathur</LastName><ForeName>Rohini</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDonald</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rentsch</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultze</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smeeth</LastName><ForeName>Liam</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tazare</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Jemma</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williamson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wing</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zheng</LastName><ForeName>Bang</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bates</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cockburn</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hester</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Hanlon</LastName><ForeName>Shaun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eavis</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarvis</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avramov</LastName><ForeName>Dima</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fowles</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parkes</LastName><ForeName>Nasreen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perera</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harrison</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khunti</LastName><ForeName>Kamlesh</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sterne</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38800803</ArticleId><ArticleId IdType="pmc">PMC11127160</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102638</ArticleId><ArticleId IdType="pii">S2589-5370(24)00217-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;13:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen I.H., Magnus P., Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023;23(4):393&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat Rev Immunol. 2023;23:618&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Fang Z., De Souza C.M., et al. Innate immune cell activation causes lung fibrosis in a humanized model of long COVID. Proc Natl Acad Sci USA. 2023;120(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10013740</ArticleId><ArticleId IdType="pubmed">36848564</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini R.A., Frere J.J., Zimering J., et al. SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model. Sci Signal. 2023;16(784)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10422867</ArticleId><ArticleId IdType="pubmed">37159520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., RECOVER Mechanistic Pathways Task Force Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12 Iqbal J, Zaidi M.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens B. How &#x201c;long covid&#x201d; is shedding light on postviral syndromes. BMJ. 2022;378</Citation><ArticleIdList><ArticleId IdType="pubmed">36130797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelic M., Ziauddeen N., Boyes M., O&#x2019;Hara M.E., Hastie C., Alwan N.A. The prevalence of stigma in a UK community survey of people with lived experience of long COVID. Lancet. 2022;400</Citation></Reference><Reference><Citation>Williamson A.E., Tydeman F., Miners A., Pyper K., Martineau A.R. Short-term and long-term impacts of COVID-19 on economic vulnerability: a population-based longitudinal study (COVIDENCE UK) BMJ Open. 2022;12(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9402446</ArticleId><ArticleId IdType="pubmed">35998959</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K.K., Brown D.A., McDuff K., et al. Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study. BMJ Glob Health. 2023;8(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9979585</ArticleId><ArticleId IdType="pubmed">36863719</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/5january2023 [cited 2023&#xa0;Jan 11]. Available from:</Citation></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C., Lacey A., Cook S., et al. Post-COVID-19 condition and persisting symptoms in English schoolchildren: repeated surveys to March 2022. BMC Infect Dis. 2023;23(1):201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10075149</ArticleId><ArticleId IdType="pubmed">37020190</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie C.E., Lowe D.J., McAuley A., et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund L.C., Hallas J., Nielsen H., et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. Long COVID: 3 years in. Lancet. 2023;401(10379):795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9998094</ArticleId><ArticleId IdType="pubmed">36906338</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E., Gallagher A.M., Bhaskaran K., et al. Data resource profile: clinical practice research datalink (CPRD) Int J Epidemiol. 2015;44(3):827&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer R., Mathur R., Bhaskaran K., Eastwood S.V., Chaturvedi N., Smeeth L. Promises and pitfalls of electronic health record analysis. Diabetologia. 2018;61(6):1241&#x2013;1248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447497</ArticleId><ArticleId IdType="pubmed">29247363</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M., Pedersen L., S&#xf8;rensen H.T. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">24965263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemingway H., Asselbergs F.W., Danesh J., et al. Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Eur Heart J. 2018;39(16):1481&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6019015</ArticleId><ArticleId IdType="pubmed">29370377</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.J., MacKenna B., Inglesby P., et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021;71(712):e806&#x2013;e814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>Strasser Z.H., Dagliati A., Abad Z.S.H., et al. A&#xa0;retrospective cohort analysis leveraging augmented intelligence to characterize long COVID in the electronic health record: a precision medicine framework. PLoS Digit Health. 2023;2(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10368277</ArticleId><ArticleId IdType="pubmed">37490472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health. 2022;4(7):e532&#x2013;e541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Madlock-Brown C., Baratta J.M., et al. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21(1):58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang C., Zhang Y., Xu J., et al. Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative. Nat Commun. 2023;14(1):1948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10080528</ArticleId><ArticleId IdType="pubmed">37029117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Albers D.J. Next-generation phenotyping of electronic health records. J&#xa0;Am Med Inform Assoc. 2013;20(1):117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerman B.A., Garc&#xed;a-Alb&#xe9;niz X., Logan R.W., Denaxas S., Hern&#xe1;n M.A. Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med. 2019;25(10):1601&#x2013;1606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7076561</ArticleId><ArticleId IdType="pubmed">31591592</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Digital  Patient online management information (POMI) https://digital.nhs.uk/data-and-information/publications/statistical/mi-patient-online-pomi/current [cited 2024 Feb 16]. Available from:</Citation></Reference><Reference><Citation>Routen A., O&#x2019;Mahoney L., Aiyegbusi O.L., et al. Patient and public involvement within epidemiological studies of long COVID in the UK. Nat Med. 2023;29(4):771&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">36932242</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E., Tomlin K., Lin L.Y., et al. Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT) BMJ Open. 2023;13(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9943695</ArticleId><ArticleId IdType="pubmed">36806073</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Digital  SNOMED CT. https://digital.nhs.uk/services/terminology-and-classifications/snomed-ct [cited 2024 Feb 12]. Available from:</Citation></Reference><Reference><Citation>Schneeweiss S., Rassen J.A., Brown J.S., et al. Graphical depiction of longitudinal study designs in health care databases. Ann Intern Med. 2019;170(6):398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">30856654</ArticleId></ArticleIdList></Reference><Reference><Citation>OpenCodelists: NICE managing the long-term effects of COVID-19. https://www.opencodelists.org/codelist/opensafely/nice-managing-the-long-term-effects-of-covid-19/64f1ae69/ [cited 2023 Feb 15]. Available from:</Citation></Reference><Reference><Citation>OpenCodelists: referral and signposting for long COVID. https://www.opencodelists.org/codelist/opensafely/referral-and-signposting-for-long-covid/12d06dc0/#full-list [cited 2023 Feb 15]. Available from:</Citation></Reference><Reference><Citation>OpenCodelists: assessment instruments and outcome measures for long covid. https://www.opencodelists.org/codelist/opensafely/assessment-instruments-and-outcome-measures-for-long-covid/79c0fa8a/#full-list Available from:</Citation></Reference><Reference><Citation>Parker E.P.K., Horne E.M.F., Hulme W.J., et al.  Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study. Lancet Reg Health Eur. 2023;30 https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00055-8/fulltext [cited 2023 May 19];0(0). Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10155829</ArticleId><ArticleId IdType="pubmed">37363796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulme W.J., Horne E.M.F., Parker E.P.K., et al. Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP. BMJ. 2023;380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10014664</ArticleId><ArticleId IdType="pubmed">36921925</ArticleId></ArticleIdList></Reference><Reference><Citation>OpenCodelists: ethnicity (SNOMED) https://www.opencodelists.org/codelist/opensafely/ethnicity-snomed-0removed/2e641f61/ [cited 2023 Feb 15]. Available from:</Citation></Reference><Reference><Citation>OpenCodelists: high risk from COVID-19 code. https://www.opencodelists.org/codelist/primis-covid19-vacc-uptake/shield/v1/#full-list [cited 2023 Feb 15]. Available from:</Citation></Reference><Reference><Citation>Cases in England | coronavirus in the UK. 2023. https://coronavirus.data.gov.uk/details/cases?areaType=nation&amp;areaName=England [cited 2023 Apr 27]. Available from:</Citation></Reference><Reference><Citation>Tudor Hart J. The inverse care law. Lancet. 1971;297(7696):405&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">4100731</ArticleId></ArticleIdList></Reference><Reference><Citation>The &#x2018;five safes&#x2019; framework and applying it to OpenSAFELY | Bennett Institute for applied data science. https://www.bennett.ox.ac.uk/blog/2023/03/the-five-safes-framework-and-applying-it-to-opensafely/ [cited 2023 Aug 29]. Available from:</Citation></Reference><Reference><Citation>Abuabara K., Magyari A.M., Hoffstad O., et al. Development and validation of an algorithm to accurately identify atopic eczema patients in primary care electronic health records from the UK. J&#xa0;Invest Dermatol. 2017;137(8):1655&#x2013;1662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5883318</ArticleId><ArticleId IdType="pubmed">28428130</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha D., Asselbergs F.W., Achenbach S., et al. CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research. Lancet Digit Health. 2022;4(10):e757&#x2013;e764.</Citation><ArticleIdList><ArticleId IdType="pubmed">36050271</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel D.G., Rosella L.C., Stukel T.A. Importance of accurately identifying disease in studies using electronic health records. BMJ. 2010;341:c4226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20724404</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuppel A., Boyd A., Macleod J., Chaturvedi N., Williams D.M. The long COVID evidence gap: comparing self-reporting and clinical coding of long COVID using longitudinal study data linked to healthcare records. medRxiv. 2023 https://www.medrxiv.org/content/10.1101/2023.02.10.23285717v1 [cited 2023 Aug 17]. p. 2023.02.10.23285717. Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.10.23285717v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.D., Subramanian A., Lewis J., et al. Long Covid symptoms and diagnosis in primary care: a cohort study using structured and unstructured data in the Health Improvement Network primary care database. PLoS One. 2023;18(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10521988</ArticleId><ArticleId IdType="pubmed">37751444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.G., Honerlaw J.P., Maripuri M., et al. Potential pitfalls in the use of real-world data for studying long COVID. Nat Med. 2023;29:1040&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10205658</ArticleId><ArticleId IdType="pubmed">37055567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Evans P.H.I., Baldwin M.M., Daynes E., et al. Early experiences of the Your COVID Recovery&#xae; digital programme for individuals with long COVID. BMJ Open Respir Res. 2022;9(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9527747</ArticleId><ArticleId IdType="pubmed">36171050</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin M.M., Daynes E., Chaplin E., et al. Public use of the &#x201c;Your COVID Recovery&#x201d; website designed to help individuals manage their COVID-19 Recovery: observational study. JMIR Form Res. 2023;7(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9872975</ArticleId><ArticleId IdType="pubmed">36626648</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L., Mulholland R.H., Vasileiou E., et al. Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data. BMJ Open. 2022;12(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9260199</ArticleId><ArticleId IdType="pubmed">35793922</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Torres B., Delanerolle G., Okusi C., et al. Differences in clinical presentation with long COVID after community and hospital infection and associations with all-cause mortality: English sentinel network database study. JMIR Public Health Surveill. 2022;8(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384859</ArticleId><ArticleId IdType="pubmed">35605170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D. Long COVID and significant activity limitation among adults, by age &#x2014; United States, june 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):866&#x2013;870. https://www.cdc.gov/mmwr/volumes/72/wr/mm7232a3.htm [cited 2023 Aug 15];72. Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 2023;41(11):1783&#x2013;1790. https://www.sciencedirect.com/science/article/pii/S0264410X23001342 [cited 2023 Feb 13]; Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>UKHSA COVID-19 Evidence Team  . UKHSA COVID-19 Evidence Team; 2022. The effectiveness of vaccination against long COVID: a rapid evidence briefing.https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff Available from:</Citation></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., et al. Risk factors associated with Post&#x2212;COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750. [cited 2023 Mar 29]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1) https://bmjmedicine.bmj.com/content/2/1/e000385 [cited 2023 Mar 13]; Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Woldegiorgis M., Cadby G., Ngeh S., et al.  Long COVID in a highly vaccinated population infected during a SARS-CoV-2 Omicron wave &#x2013; Australia, 2022. medRxiv. 2023 https://www.medrxiv.org/content/10.1101/2023.08.06.23293706v1 [cited 2023 Aug 18]. p. 2023.08.06.23293706. Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.08.06.23293706v1</ArticleId><ArticleId IdType="pubmed">38508863</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M., Mercad&#xe9;-Besora N., Kolde R., et al.  The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. 2024;12(3):225&#x2013;236. https://www.sciencedirect.com/science/article/pii/S2213260023004149 [cited 2024 Feb 16]; Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2(1) https://bmjmedicine.bmj.com/content/2/1/e000229 [cited 2023 Mar 13]; Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Hamdh B., Nazzal Z. A&#xa0;prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Sci Rep. 2023;13(1):4896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039348</ArticleId><ArticleId IdType="pubmed">36966161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Zayyad H., et al. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. NPJ Vaccines. 2022;7(1):101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento T.C.D.C., do Valle Costa L., Ruiz A.D., et al. Vaccination status and long COVID symptoms in patients discharged from hospital. Sci Rep. 2023;13(1):2481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9922040</ArticleId><ArticleId IdType="pubmed">36774419</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain W.D., Sherwood O., Banerjee A., Van der Togt V., Hishmeh L., Rossman J. The impact of COVID vaccination on symptoms of long COVID: an international survey of people with lived experience of long COVID. Vaccines. 2022;10(5):652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert C.R., Strahm C., G&#xfc;sewell S., et al. Post-acute sequelae after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by viral variant and vaccination status: a multicenter cross-sectional study. Clin Infect Dis. 2023;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10371307</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M., Wang R., Yu H., et al. Severe fatigue and persistent symptoms at three months following SARS-CoV-2 infections during the pre-delta, delta, and omicron time periods: a multicenter prospective cohort study. Clin Infect Dis. 2023;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249989</ArticleId><ArticleId IdType="pubmed">36705268</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds C.J., Gibbons J.M., Pade C., et al. Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants. Science. 2022;375(6577):183&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10186585</ArticleId><ArticleId IdType="pubmed">34855510</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet Lond Engl. 2022;399(10343):2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffrey K., Woolford L., Maini R., et al. Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study. EClinicalMedicine. 2024;71:102590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11016856</ArticleId><ArticleId IdType="pubmed">38623399</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker E.P.K., Desai S., Marti M., et al. Emerging evidence on heterologous COVID-19 vaccine schedules&#x2014;to mix or not to mix? Lancet Infect Dis. 2022;22(4):438&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906806</ArticleId><ArticleId IdType="pubmed">35278358</ArticleId></ArticleIdList></Reference><Reference><Citation>Atmar R.L., Lyke K.E., Deming M.E., et al. Homologous and heterologous covid-19 booster vaccinations. N&#xa0;Engl J Med. 2022;386(11):1046&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820244</ArticleId><ArticleId IdType="pubmed">35081293</ArticleId></ArticleIdList></Reference><Reference><Citation>Au W.Y., Cheung P.P.H. Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis. BMJ. 2022;377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724446</ArticleId><ArticleId IdType="pubmed">35640925</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N., Stowe J., Kirsebom F., et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022;28(4):831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9018410</ArticleId><ArticleId IdType="pubmed">35045566</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team R  . 2011. R: a language and environment for statistical computing; p. 409.http://www.r-project.org Vol. 1. Available from:</Citation></Reference><Reference><Citation>Curtis H.J., Inglesby P., Morton C.E., et al. Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients&#x2019; primary care records in situ using OpenSAFELY. Br J Gen Pract. 2022;72(714):e51&#x2013;e62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589463</ArticleId><ArticleId IdType="pubmed">34750106</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>